FI906008A - Menetelmä heterosyklisen yhdisteen vesipitoisen seoksen stabiloimiseksi - Google Patents

Menetelmä heterosyklisen yhdisteen vesipitoisen seoksen stabiloimiseksi Download PDF

Info

Publication number
FI906008A
FI906008A FI906008A FI906008A FI906008A FI 906008 A FI906008 A FI 906008A FI 906008 A FI906008 A FI 906008A FI 906008 A FI906008 A FI 906008A FI 906008 A FI906008 A FI 906008A
Authority
FI
Finland
Prior art keywords
methionine
stabilizing
heterocyclic compound
stabilized
aqueous mixture
Prior art date
Application number
FI906008A
Other languages
English (en)
Swedish (sv)
Other versions
FI906008A0 (fi
FI97689B (fi
FI97689C (fi
Inventor
Den Oetelaar Petrus Johann Van
Maria Martina Francisc Mentink
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of FI906008A0 publication Critical patent/FI906008A0/fi
Publication of FI906008A publication Critical patent/FI906008A/fi
Publication of FI97689B publication Critical patent/FI97689B/fi
Application granted granted Critical
Publication of FI97689C publication Critical patent/FI97689C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
FI906008A 1989-12-06 1990-12-05 Menetelmä heterosyklisen yhdisteen vesipitoisen seoksen stabiloimiseksi FI97689C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP89203092 1989-12-06
EP89203092 1989-12-06

Publications (4)

Publication Number Publication Date
FI906008A0 FI906008A0 (fi) 1990-12-05
FI906008A true FI906008A (fi) 1991-06-07
FI97689B FI97689B (fi) 1996-10-31
FI97689C FI97689C (fi) 1997-02-10

Family

ID=8202518

Family Applications (1)

Application Number Title Priority Date Filing Date
FI906008A FI97689C (fi) 1989-12-06 1990-12-05 Menetelmä heterosyklisen yhdisteen vesipitoisen seoksen stabiloimiseksi

Country Status (15)

Country Link
US (1) US5082864A (fi)
EP (1) EP0431663B1 (fi)
JP (1) JP2977912B2 (fi)
KR (1) KR0185377B1 (fi)
AT (1) ATE99943T1 (fi)
AU (1) AU628768B2 (fi)
CA (1) CA2030773C (fi)
DE (1) DE69005992T2 (fi)
DK (1) DK0431663T3 (fi)
ES (1) ES2062310T3 (fi)
FI (1) FI97689C (fi)
IE (1) IE63985B1 (fi)
NZ (1) NZ236332A (fi)
PT (1) PT96096B (fi)
ZA (1) ZA909568B (fi)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USH1591H (en) * 1992-10-09 1996-09-03 Fulcher; John Preparation of flavor-enhanced reduced calorie fried foods
IL107887A (en) * 1992-12-08 2003-07-06 Ambi Inc Stabilized lanthionine containing bacteriocin compositions
US6197830B1 (en) 1995-09-22 2001-03-06 Bruce M. Frome Method for achieving relief from sympathetically mediated pain
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
EP0813873B1 (en) * 1996-06-19 2002-02-13 Akzo Nobel N.V. Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
IL123716A (en) * 1997-03-27 2001-03-19 Akzo Nobel Nv Therapeutic combinations of mirtazapine and an antipsychotic agent
ATE254918T1 (de) * 1998-04-02 2003-12-15 Akzo Nobel Nv Orale flüssige lösung enthaltend das antidepressivum mirtazapine
US6211171B1 (en) 1998-05-19 2001-04-03 Dalhousie University Use of antidepressants for local analgesia
US6495534B2 (en) * 2000-05-15 2002-12-17 Pharmacia & Upjohn Spa Stabilized aqueous suspensions for parenteral use
US6399310B1 (en) 2001-02-12 2002-06-04 Akzo Nobel N.V. Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4
WO2002064735A2 (en) * 2001-02-12 2002-08-22 Akzo Nobel N.V. Methods for improving the treatment of major depression by genotyping for the gene for apolipoproteine e4
US20030105082A1 (en) * 2001-12-03 2003-06-05 Murphy Greer Marechal Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4
US20050215552A1 (en) * 2002-05-17 2005-09-29 Gadde Kishore M Method for treating obesity
RU2350327C2 (ru) 2003-04-29 2009-03-27 Ориксиджен Серапьютикс, Инкорпорэйтд Составы, вызывающие потерю веса
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
WO2005070461A2 (en) * 2004-01-13 2005-08-04 Duke University Compositions of an anticonvulsant and an antipsychotic drug for affecting weight loss
WO2006023703A2 (en) * 2004-08-20 2006-03-02 Cypress Bioscience, Inc. Method for treating sleep related breathing disorders
US20060058390A1 (en) * 2004-09-14 2006-03-16 Molecular Therapeutics, Inc. D-methionine formulation with improved biopharmaceutical properties
WO2006055854A2 (en) * 2004-11-17 2006-05-26 Cypress Bioscience, Inc. Methods for reducing the side effects associated with mirtazapine treatment
EP3132792B1 (en) 2005-11-22 2019-09-11 Nalpropion Pharmaceuticals, Inc. Composition and methods for increasing insulin sensitivity
AU2007207606A1 (en) * 2006-01-17 2007-07-26 Regents Of The University Of Colorado Central administration of stable formulations of therapeutic agents for CNS conditions
US8916195B2 (en) 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
KR20140088619A (ko) 2006-11-09 2014-07-10 오렉시젠 세러퓨틱스 인크. 단위 용량 팩키지
KR101479324B1 (ko) 2006-11-09 2015-01-05 오렉시젠 세러퓨틱스 인크. 신속하게 용해되는 중간층을 포함하는 층상의 약제학적 제형
WO2008157094A1 (en) * 2007-06-13 2008-12-24 Cypress Bioscience, Inc. Improving the tolerability of mirtazapine and a second active by using them in combination
MX2010012909A (es) * 2008-05-30 2011-02-25 Orexigen Therapeutics Inc Metodos para tratamiento de condiciones de grasa visceral.
JP6196041B2 (ja) 2010-01-11 2017-09-13 オレキシジェン・セラピューティクス・インコーポレーテッド 大うつ病を有する患者において減量療法を提供する方法
MA37714A1 (fr) 2012-06-06 2017-12-29 Orexigen Therapeutics Inc Méthodes de traitement de la surcharge pondérale et de l'obésité
KR101652081B1 (ko) 2014-12-30 2016-08-30 김인호 전극보일러 급탕시스템
EP3261645B1 (en) 2015-02-27 2021-04-28 Dechra Limited Stimulation of appetite, management of weight loss, and treatment of anorexia in dogs and cats
KR20170001494A (ko) 2015-06-26 2017-01-04 김인호 전극보일러 전류제어시스템
CN108853042B (zh) * 2018-09-20 2021-03-26 北京哈三联科技有限责任公司 一种米氮平冻干口崩片及其制备方法和应用
GR1009883B (el) * 2019-06-07 2020-12-11 Λαμδα Φαρμακευτικα Εργαστηρια Εφαρμοσμενης Ερευνας Και Αναπτυξης Α.Ε. Ποσιμα φαρμακευτικα διαλυματα που περιλαμβανουν υδροχλωρικη νορτριπτυλινη

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2082910A (en) * 1980-08-28 1982-03-17 Berk Pharmaceuticals Ltd Anti-depressant compositions
US4603131A (en) * 1982-04-26 1986-07-29 Bernstein Joel E Method and composition for treating and preventing irritation of the mucous membranes of the nose
DE3247676A1 (de) * 1982-12-23 1984-06-28 A. Nattermann & Cie GmbH, 5000 Köln Galenische form fuer amitriptylinoxid und verfahren zur herstellung

Also Published As

Publication number Publication date
KR910011250A (ko) 1991-08-07
DE69005992T2 (de) 1994-05-05
CA2030773A1 (en) 1991-06-07
NZ236332A (en) 1992-07-28
PT96096A (pt) 1991-09-30
EP0431663B1 (en) 1994-01-12
JP2977912B2 (ja) 1999-11-15
US5082864A (en) 1992-01-21
PT96096B (pt) 1998-02-27
FI906008A0 (fi) 1990-12-05
AU628768B2 (en) 1992-09-17
CA2030773C (en) 2001-07-24
IE904226A1 (en) 1991-06-19
IE63985B1 (en) 1995-06-28
AU6779890A (en) 1991-06-13
KR0185377B1 (ko) 1999-05-01
FI97689B (fi) 1996-10-31
EP0431663A1 (en) 1991-06-12
ES2062310T3 (es) 1994-12-16
ATE99943T1 (de) 1994-01-15
JPH05262651A (ja) 1993-10-12
DK0431663T3 (da) 1994-03-07
ZA909568B (en) 1991-09-25
DE69005992D1 (de) 1994-02-24
FI97689C (fi) 1997-02-10

Similar Documents

Publication Publication Date Title
FI906008A (fi) Menetelmä heterosyklisen yhdisteen vesipitoisen seoksen stabiloimiseksi
ITMI921203A1 (it) Derivati di s-triazina come agenti fotostabilizzanti
DK506587A (da) Imidderivater
DK0675717T3 (da) Anvendelse af 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol (pramipexol) som lægemiddel med antidepressiv virknin
SE9702305D0 (sv) New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives
DK160876C (da) Imidazoquinoxalinforbindelser, fremgangsmaade til deres fremstilling, anvendelse af forbindelserne og farmaceutiske praeparater, hvori forbindelserne indgaar
DK288287D0 (da) Heterocycliske forbindelser samt farmaceutiske praeparater til behandling af allergiske eller inflammatoriske tilstande
ATE40823T1 (de) Verwendung von loesungsmitteln bei der herstellung von s-triazinderivaten und verfahren zur herstellung von s-triazinderivaten.
DE68905414T2 (de) 2-substituierte paraaminophenole und ihre verwendung fuer die faerbung von keratinischen fasern.
NO903430D0 (no) Fremgangsmaate for fremstilling av aminoketonderivater.
DE68921051D1 (de) Pyridin-3-percarboxylsäure monopersulfat.
SE7514294L (sv) 4,4'-bis-/2",4"-bis-(diisopropanolamino)-s-triazin-6"-ylamino/-stilben-2,2'-disulfonsyra, dess framstellning och dess anvendning som optiskt vithetsforhojande medel
FI870994A0 (fi) Foerfarande foer framstaellning av stabila, injekterbara farmaceutiska kompositioner, vilka innehaoller 1,4-dihydroxi-5,8-bis/2-(2-hydroxietylamino)etylamino/ antrakinondihydroklorid.
AU6565886A (en) Oligomericdiazaoxaspirodecanes, preparation thereof and use thereof as light stabilizers for polymers
DE68917394T2 (de) Verfahren zur Herstellung von Oxazolinderivaten.
DK0457215T3 (da) 3-deamino-4-desoxy-4-amino-8-fluoranthracycliner samt fremgangsmåder til fremstilling deraf
NO179072C (no) Glutarsyrederivater, samt fremstilling derav
FI903950A0 (fi) Ny komposition.
DK46884A (da) 5-aminomethyl-imidazol-1-yl-1,3-dialkyl-1h-pyrazol-4-yl-aroyl-methanoner, fremgangsmaade til deres fremstilling samt deres anvendelse
DE3772926D1 (de) Verfahren zur stabilisierung von procaterol.
DK104691A (da) Cykliske imidatestere til anvendelse som udgangsmateriale ved fremstillling af 1,4-dihydropyrid-5-yl-(cyklisk imidat)estere

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: AKZO N.V.

PC Transfer of assignment of patent

Owner name: N.V. ORGANON

Free format text: N.V. ORGANON